Literature DB >> 16830236

[Palliative symptom control in malignant bowel obstruction due to advanced ovarian cancer].

Kurt Alker1, Franz Harnoncourt.   

Abstract

This case study deals with symptom control of malignant bowel obstruction in patients suffering from recurrent ovarian carcinoma. The objective of the paper is to analyse various options of medical and surgical treatment. Relevant factors which have to be considered when deciding on the most efficient and adequate therapeutical approach are discussed and elaborated on.

Entities:  

Mesh:

Year:  2006        PMID: 16830236     DOI: 10.1007/s10354-006-0279-4

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  15 in total

1.  Loss of interstitial cells of Cajal and development of electrical dysfunction in murine small bowel obstruction.

Authors:  I Y Chang; N J Glasgow; I Takayama; K Horiguchi; K M Sanders; S M Ward
Journal:  J Physiol       Date:  2001-10-15       Impact factor: 5.182

2.  Medical management of intestinal obstruction in patients with advanced malignant disease. A clinical and pathological study.

Authors:  M Baines; D J Oliver; R L Carter
Journal:  Lancet       Date:  1985-11-02       Impact factor: 79.321

3.  Percutaneous gastrostomy for decompression in patients with advanced gynecologic malignancies.

Authors:  M J Cunningham; C Bromberg; D C Kredentser; M B Collins; J H Malfetano
Journal:  Gynecol Oncol       Date:  1995-11       Impact factor: 5.482

4.  Gastrostomy tubes in patients with recurrent gynaecological cancer and intestinal obstruction.

Authors:  E Tsahalina; R P Woolas; P G Carter; F Chan; M E Gore; P M Blake; J H Shepherd; D P Barton
Journal:  Br J Obstet Gynaecol       Date:  1999-09

Review 5.  Current management of small-bowel obstruction.

Authors:  K N Bass; B Jones; G B Bulkley
Journal:  Adv Surg       Date:  1997

6.  Octreotide in relieving gastrointestinal symptoms due to bowel obstruction.

Authors:  S Mercadante; E Spoldi; A Caraceni; S Maddaloni; M T Simonetti
Journal:  Palliat Med       Date:  1993       Impact factor: 4.762

7.  Benefit of palliative surgery for bowel obstruction in advanced ovarian cancer.

Authors:  P Jong; J Sturgeon; C G Jamieson
Journal:  Can J Surg       Date:  1995-10       Impact factor: 2.089

8.  Palliation of malignant intestinal obstruction using octreotide.

Authors:  D Khoo; E Hall; R Motson; J Riley; K Denman; J Waxman
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

Review 9.  Management of bowel obstruction in advanced cancer.

Authors:  C Ripamonti
Journal:  Curr Opin Oncol       Date:  1994-07       Impact factor: 3.645

Review 10.  The role of somatostatin and octreotide in bowel obstruction: pre-clinical and clinical results.

Authors:  C Ripamonti; C Panzeri; L Groff; G Galeazzi; R Boffi
Journal:  Tumori       Date:  2001 Jan-Feb
View more
  1 in total

1.  [Methods of symptom control in malignant ascites].

Authors:  Astrid Bodisch; Christian Muschitz; Meinolf Karthaus
Journal:  Wien Med Wochenschr       Date:  2008
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.